1. Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona

2. Carotid Bifurcation US Femoral Bifurcation US Arterial Segments Commonly Involved in Atherosclerosis

3. Subclinical Atherosclerosis Adapated from Naqvi TZ, Lee MS. JACC Cardiovasc Imaging.Adapated from Naqvi TZ, Lee MS. JACC Cardiovasc Imaging. 2014 Oct;7(10):1025-38

4. Value in Clinical Practice

5. 53 yr old male T chol: 251 HDL 53 LDL 167 TG 70 Framingham risk:11% Case

6. 61 yr old female Total cholesterol 216 HDL 50 LDL 143 Triglycerides 239 mg/dl FRS 6% Case

7. Case: My patient is not compliant..  50 yr old Caucasian female, history of DM, non compliant with diet or lipid lowering agents

9. Case: 45 year old male HTN,h/o of RCA stent 3 yrs ago, -ve stress echo Would not take statins

10. Case: 45 year old male HTN,h/o of RCA stent 3 yrs ago, -ve stress echo Would not take statins

11. Case: I am Intolerant to Statins and Would not take’m 67 M CABG Inf MI, EF 40% Recent LCX Stent Naqvi TZ. J Am Soc Echocardiogr. 2015 May; 28(5):A16-7

12. Summary  CIMT and plaque imaging is feasible in clinical practice in primary prevention setting and can improve CVD risk prediction over conventional methods  CIMT and plaque imaging can detect atherosclerosis burden in secondary prevention setting and improve patient compliance Common Carotid

13. naqvi.tasneem@mayo.edu